Mycoplasma Testing Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

The mycoplasma testing detects mycoplasma pneumoniae, which causes mycoplasma pneumonia. Mycoplasma pneumonia is a contagious respiratory infection that spreads easily through contact with respiratory fluids. It can cause epidemics. Mycoplasma testing includes a group of tests that measures antibodies in the blood produced in response to a mycoplasma infection and detects the microbe directly through detecting or culturing its genetic material (DNA) in a body sample.

Sizing and Forecast
The mycoplasma testing market size has grown rapidly in recent years. It will grow from $0.94 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 14.0%.  The growth in the historic period can be attributed to outbreaks and contamination incidents, increased awareness, biotechnology sector expansion, research and development initiatives, healthcare industry trends, rise in cell culture production.

The mycoplasma testing market size is expected to see rapid growth in the next few years. It will grow to $1.71 billion in 2028 at a compound annual growth rate (CAGR) of 12.2%.  The growth in the forecast period can be attributed to demand for quality assurance, emerging market demand, biopharmaceutical industry growth, rise in cell-based therapies, expansion of biotechnology sector. Major trends in the forecast period include regulatory standards and compliance, healthcare awareness and diagnostics, global pandemic preparedness, point-of-care testing innovation, market penetration in emerging economies.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Segmentation & Regional Insights
The mycoplasma testing market covered in this report is segmented –
1) By Product: Instruments, Assay, Kits, and Reagents
2) By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies
3) By Application: Cell line Testing, Virus Testing, End- of- Production Cell Testing
4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes

North America was the largest region in the mycoplasma testing market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of mycoplasma pneumonia is expected to propel the growth of the mycoplasma testing market going forward. Mycoplasma pneumonia refers to a respiratory infection caused by the bacteria Mycoplasma pneumoniae. Mycoplasma testing plays a crucial role in diagnosing Mycoplasma pneumonia by detecting the presence of Mycoplasma pneumoniae bacteria in respiratory specimens, aiding in the timely and accurate identification of the infection for appropriate medical treatment and management. For instance, in December 2023, according to the Centers for Disease Control and Prevention, a US-based government agency An estimated 2 million cases of Mycoplasma pneumoniae infections occur each year in the United States. Therefore, the increasing prevalence of mycoplasma pneumonia is driving the growth of the mycoplasma testing market.

Key Industry Players
Major companies operating in the mycoplasma testing market report are Abbott Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Boston Scientific Corporation, Olympus Corporation, Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Smith & Nephew plc, Charles River Laboratories International Inc., CONMED Corporation, Nelson Laboratories Fairfield Inc., AngioDynamics Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc., AtriCure Inc., Advanced Cardiac Therapeutics Inc., ARTWORKSIT

The mycoplasma testing market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model